775 CK Life Sciences International (Holdings), Inc. HKEX · Hong Kong

CK Life Sciences International (Holdings) (775) news

CK Life Sciences International (Holdings), Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 775, recorded under Hong Kong. The directory classifies it as Mixed biopharma / other operations. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest CK Life Sciences International (Holdings) news

We have not published a story on CK Life Sciences International (Holdings) yet. When there is news, it will appear here.

Questions about CK Life Sciences International (Holdings)

What is the ticker symbol of CK Life Sciences International (Holdings)?

CK Life Sciences International (Holdings), Inc. trades under the ticker 775 on HKEX.

Where is CK Life Sciences International (Holdings) listed?

CK Life Sciences International (Holdings), Inc. is listed on HKEX.

Which country or territory is CK Life Sciences International (Holdings) listed under?

Our directory records CK Life Sciences International (Holdings), Inc. under Hong Kong.

What does CK Life Sciences International (Holdings) do?

Our directory classifies CK Life Sciences International (Holdings), Inc. as: Mixed biopharma / other operations. This is a directory classification, not a description of the pipeline.

What is the ISIN of CK Life Sciences International (Holdings)?

The ISIN recorded for CK Life Sciences International (Holdings), Inc. is KYG2176J1058.

Does aibio.space cover CK Life Sciences International (Holdings)?

aibio.space lists CK Life Sciences International (Holdings), Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to CK Life Sciences International (Holdings)?

Companies in our directory listed in the same country and business area as CK Life Sciences International (Holdings): InSilico Medicine Cayman TopCo, China Traditional Chinese Medicine Holdings Co., China Biotech Services Holdings, Shenzhen Neptunus Interlong Bio-Technique Co., HUTCHMED (China), United Laboratories International Holdings.

Investor discussion: CK Life Sciences International (Holdings)

Members talk about CK Life Sciences International (Holdings) (775). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at CK Life Sciences International (Holdings), newest first. Each line links the filing it comes from.

Oct 8, 2025Mergers
Transaction under the Listing Rules: DISCLOSEABLE TRANSACTIONS IN RELATION TO (1) MEMBERSHIP INTEREST PURCHASE AGREEMENT AND (2) INVESTMENT AGREEMENT. Source
Sep 26, 2025Mergers
Transaction under the Listing Rules: ANNOUNCEMENT PURSUANT TO RULE 14.36 OF THE LISTING RULES AND CONNECTED TRANSACTION IN RELATION TO PARTIAL WAIVER. Source
Apr 11, 2025Listings
Trading status: EXCHANGE NOTICE - RESUMPTION OF TRADING. Source
Apr 11, 2025Listings
Trading status: INSIDE INFORMATION - PROMISING EARLY RESULTS OF NOVEL CANCER VACCINES TARGETING TROP2 (TROPHOBLAST CELL SURFACE ANTIGEN 2) AND RESUMPTION OF TRADING. Source
Apr 10, 2025Listings
Trading status: TRADING HALT. Source
Apr 10, 2025Listings
Trading status: EXCHANGE NOTICE - TRADING HALT. Source
Mar 12, 2025Mergers
Transaction under the Listing Rules: ANNOUNCEMENT PURSUANT TO RULE 14.36 OF THE LISTING RULES AND CONNECTED TRANSACTION IN RELATION TO CONVERSION OF LOAN. Source

Press releases

Headlines of CK Life Sciences International (Holdings)'s own announcements, newest first. Each opens the full release on the newswire that carried it.

Aug 11, 2026HKEXnews
Announcement - Interim Results for 2026
May 21, 2026HKEXnews
ANNUAL GENERAL MEETING HELD ON 21ST MAY, 2026 - POLL RESULTS
May 8, 2026HKEXnews
RESIGNATION OF EXECUTIVE DIRECTOR, VICE PRESIDENT AND CHIEF EXECUTIVE OFFICER AND RE-DESIGNATION OF EXECUTIVE DIRECTOR
Apr 17, 2026HKEXnews
Notice of Annual General Meeting
Apr 17, 2026HKEXnews
Notification Letter to Registered Holder - Annual General Meeting
Mar 31, 2026HKEXnews
BUSINESS UPDATE ON PRECLINICAL STUDIES OF CANCER VACCINES
Mar 17, 2026HKEXnews
Annual Results for 2025
Mar 10, 2026HKEXnews
VOLUNTARY ANNOUNCEMENT RELATING TO ESTABLISHMENT OF SEQUENCIO THERAPEUTICS COMPANY LIMITED TO ADVANCE THERAPEUTIC CANCER VACCINES DEVELOPMENT
Dec 22, 2025HKEXnews
BUSINESS UPDATE ON DOGWOOD THERAPEUTICS, INC.
Dec 19, 2025HKEXnews
Continuing Connected Transactions - Provision of Management Services
Oct 8, 2025HKEXnews
DISCLOSEABLE TRANSACTIONS IN RELATION TO (1) MEMBERSHIP INTEREST PURCHASE AGREEMENT AND (2) INVESTMENT AGREEMENT
Sep 26, 2025HKEXnews
ANNOUNCEMENT PURSUANT TO RULE 14.36 OF THE LISTING RULES AND CONNECTED TRANSACTION IN RELATION TO PARTIAL WAIVER
Aug 12, 2025HKEXnews
Announcement - Interim Results for 2025
Jul 31, 2025HKEXnews
PROFIT WARNING
May 22, 2025HKEXnews
Terms of Reference of the Audit Committee
May 22, 2025HKEXnews
Terms of Reference of the Nomination Committee
May 22, 2025HKEXnews
ANNUAL GENERAL MEETING HELD ON 22ND MAY, 2025 - POLL RESULTS
Apr 22, 2025HKEXnews
BUSINESS UPDATE ON PRECLINICAL STUDIES OF CANCER VACCINES AND THE PROGRESS OF RESEARCH COLLABORATION TO DEVELOP AN AI-EMPOWERED CANCER VACCINE PLATFORM
Apr 11, 2025HKEXnews
EXCHANGE NOTICE - RESUMPTION OF TRADING
Apr 11, 2025HKEXnews
INSIDE INFORMATION - PROMISING EARLY RESULTS OF NOVEL CANCER VACCINES TARGETING TROP2 (TROPHOBLAST CELL SURFACE ANTIGEN 2) AND RESUMPTION OF TRADING

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:775 on TradingView.

Listing details

Company: CK Life Sciences International (Holdings), Inc.
Ticker: 775
Listing: HKEX
Country or territory: Hong Kong
Business scope: Mixed biopharma / other operations
ISIN: KYG2176J1058
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction